- Serious infections caused by susceptible strains of organism.
- With the exception of uncomplicated UTI, aminoglycosides are generally used in combination for serious infections.
- Bacterial septicemia, including neonatal sepsis
- Skin, bone and soft tissue infections (including burns)
- Meningitis (poor penetration)
- Urinary tract
- Respiratory tract (poor penetration)
- Gastrointestinal tract (including peritonitis)
- Inflammatory ocular conditions that are steroid-responsive (opthalmic ointment and suspension)
NON-FDA APPROVED USES
- Pneumonia, hospital-acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
- Intra-abdominal infection (in combination with an agent with Gram-positive and anaerobe coverage)
- Enterococcal endocarditis (in combination with ampicillin)
- Pelvic inflammatory disease (PID, in combination with clindamycin)
- Infections caused by P. aeruginosa (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third/fourth-generation cephalosporin)
- Brucella Species
There's more to see -- the rest of this topic is available only to subscribers.